loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Looking for Poly DL Lactide? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

Close
4

PDLLA

LM Application #LearnMore

Applications:

PDLLA (Poly-DL-lactide) is different polymers developed to formulate polymeric nanoparticles. PDLLA is biodegradable & biocompatible, and it has the FDA and EMA approval in drug delivery systems for parenteral administration.

Ingredient(s): Poly DL Lactide

Dosage Form: Tablet

Category: Controlled & Modified Release

Route of Administration (Grade): Oral, Parenteral
Pharmacopoeia Reference: NA

Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY